Timing of Levodopa Treatment in Parkinson's Disease
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
The ELLDOPA study is a controlled clinical trial in patients with newly diagnosed PD to
determine the optimal timing and dosing with levodopa (Sinemet or its generic equivalents).
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)